Day One Biopharmaceuticals Stock Price Patterns
| DAWN Stock | USD 11.16 0.34 2.96% |
Momentum 66
Buy Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.29) | EPS Estimate Current Year (0.94) | EPS Estimate Next Year (0.60) | Wall Street Target Price 22.4444 | EPS Estimate Current Quarter (0.28) |
Using Day One hype-based prediction, you can estimate the value of Day One Biopharmaceuticals from the perspective of Day One response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Day One using Day One's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Day using crowd psychology based on the activity and movement of Day One's stock price.
Day One Short Interest
An investor who is long Day One may also wish to track short interest. As short interest increases, investors should be becoming more worried about Day One and may potentially protect profits, hedge Day One with its derivative instruments, or be ready for some potential downside.
200 Day MA 7.7149 | Short Percent 0.1638 | Short Ratio 4.21 | Shares Short Prior Month 11.2 M | 50 Day MA 9.593 |
Day One Biopharmaceu Hype to Price Pattern
Investor biases related to Day One's public news can be used to forecast risks associated with an investment in Day. The trend in average sentiment can be used to explain how an investor holding Day can time the market purely based on public headlines and social activities around Day One Biopharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Day One's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Day One.
Day One Implied Volatility | 1.26 |
Day One's implied volatility exposes the market's sentiment of Day One Biopharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Day One's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Day One stock will not fluctuate a lot when Day One's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Day One to buy its stock at a price that has no basis in reality. In that case, they are not buying Day because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Day One after-hype prediction price | USD 10.59 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Day contract
Based on the Rule 16, the options market is currently suggesting that Day One Biopharmaceuticals will have an average daily up or down price movement of about 0.0788% per day over the life of the 2026-04-17 option contract. With Day One trading at USD 11.16, that is roughly USD 0.008789 . If you think that the market is fully incorporating Day One's daily price movement you should consider acquiring Day One Biopharmaceuticals options at the current volatility level of 1.26%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Day One Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Day One's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Day One After-Hype Price Density Analysis
As far as predicting the price of Day One at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Day One or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Day One, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Day One Estimiated After-Hype Price Volatility
In the context of predicting Day One's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Day One's historical news coverage. Day One's after-hype downside and upside margins for the prediction period are 4.34 and 16.84, respectively. We have considered Day One's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Day One is slightly risky at this time. Analysis and calculation of next after-hype price of Day One Biopharmaceu is based on 3 months time horizon.
Day One Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Day One is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Day One backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Day One, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.53 | 6.19 | 0.56 | 0.06 | 10 Events / Month | 7 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
11.16 | 10.59 | 5.11 |
|
Day One Hype Timeline
Day One Biopharmaceu is currently traded for 11.16. The entity has historical hype elasticity of -0.56, and average elasticity to hype of competition of 0.06. Day is anticipated to decline in value after the next headline, with the price expected to drop to 10.59. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -5.11%, whereas the daily expected return is currently at 0.53%. The volatility of related hype on Day One is about 5245.76%, with the expected price after the next announcement by competition of 11.22. About 17.0% of the company shares are held by company insiders. The book value of Day One was currently reported as 4.39. The company recorded a loss per share of 1.52. Day One Biopharmaceu had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days. Check out Day One Basic Forecasting Models to cross-verify your projections.Day One Related Hype Analysis
Having access to credible news sources related to Day One's direct competition is more important than ever and may enhance your ability to predict Day One's future price movements. Getting to know how Day One's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Day One may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GERN | Geron | 0.08 | 9 per month | 2.84 | 0.09 | 7.76 | (4.76) | 16.99 | |
| VALN | Valneva SE ADR | 0.82 | 4 per month | 2.35 | (0) | 4.83 | (4.81) | 15.59 | |
| ARVN | Arvinas | (0.39) | 7 per month | 3.12 | 0.14 | 5.91 | (5.07) | 28.90 | |
| REPL | Replimune Group | 0.06 | 13 per month | 0.00 | (0.15) | 5.56 | (5.32) | 14.00 | |
| TYRA | Tyra Biosciences | (0.50) | 8 per month | 1.75 | 0.25 | 6.05 | (3.43) | 34.11 | |
| RZLT | Rezolute | 0.92 | 22 per month | 15.25 | 0.03 | 18.05 | (9.22) | 99.29 | |
| AVBP | ArriVent BioPharma Common | (0.17) | 4 per month | 3.00 | 0.08 | 6.71 | (6.03) | 18.12 | |
| ATXS | Astria Therapeutics | 0.05 | 7 per month | 1.00 | 0.02 | 2.11 | (1.67) | 6.54 | |
| ERAS | Erasca Inc | 0.41 | 11 per month | 2.49 | 0.33 | 15.04 | (4.76) | 50.26 | |
| VIR | Vir Biotechnology | (0.1) | 7 per month | 3.40 | 0.1 | 8.08 | (6.04) | 20.46 |
Day One Additional Predictive Modules
Most predictive techniques to examine Day price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Day using various technical indicators. When you analyze Day charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Day One Predictive Indicators
The successful prediction of Day One stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Day One Biopharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Day One based on analysis of Day One hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Day One's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Day One's related companies. | 2025 | 2026 (projected) | Payables Turnover | 1.46 | 0.75 | Days Of Inventory On Hand | 206.66 | 183.7 |
Pair Trading with Day One
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Day One position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will appreciate offsetting losses from the drop in the long position's value.Moving together with Day Stock
Moving against Day Stock
| 0.81 | LYRA | Lyra Therapeutics | PairCorr |
| 0.76 | DWTX | Dogwood Therapeutics | PairCorr |
| 0.75 | ABP | Abpro Holdings | PairCorr |
| 0.69 | GNLX | Genelux Common | PairCorr |
| 0.67 | KURA | Kura Oncology | PairCorr |
| 0.62 | EDIT | Editas Medicine | PairCorr |
The ability to find closely correlated positions to Day One could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Day One when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Day One - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Day One Biopharmaceuticals to buy it.
The correlation of Day One is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Day One moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Day One Biopharmaceu moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Day One can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Day One Basic Forecasting Models to cross-verify your projections. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Will Biotechnology sector continue expanding? Could Day diversify its offerings? Factors like these will boost the valuation of Day One. Projected growth potential of Day fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Day One data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.52) | Revenue Per Share | Quarterly Revenue Growth (0.58) | Return On Assets | Return On Equity |
Investors evaluate Day One Biopharmaceu using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Day One's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Day One's market price to deviate significantly from intrinsic value.
It's important to distinguish between Day One's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Day One should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Day One's market price signifies the transaction level at which participants voluntarily complete trades.